1. Home
  2. IVVD vs AISP Comparison

IVVD vs AISP Comparison

Compare IVVD & AISP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IVVD
  • AISP
  • Stock Information
  • Founded
  • IVVD 2020
  • AISP 2006
  • Country
  • IVVD United States
  • AISP United States
  • Employees
  • IVVD N/A
  • AISP N/A
  • Industry
  • IVVD Biotechnology: Pharmaceutical Preparations
  • AISP Blank Checks
  • Sector
  • IVVD Health Care
  • AISP Finance
  • Exchange
  • IVVD Nasdaq
  • AISP Nasdaq
  • Market Cap
  • IVVD 123.8M
  • AISP 107.6M
  • IPO Year
  • IVVD 2021
  • AISP N/A
  • Fundamental
  • Price
  • IVVD $0.51
  • AISP $3.64
  • Analyst Decision
  • IVVD Strong Buy
  • AISP Strong Buy
  • Analyst Count
  • IVVD 3
  • AISP 2
  • Target Price
  • IVVD $7.52
  • AISP $9.00
  • AVG Volume (30 Days)
  • IVVD 1.7M
  • AISP 706.7K
  • Earning Date
  • IVVD 05-08-2025
  • AISP 05-14-2025
  • Dividend Yield
  • IVVD N/A
  • AISP N/A
  • EPS Growth
  • IVVD N/A
  • AISP N/A
  • EPS
  • IVVD N/A
  • AISP N/A
  • Revenue
  • IVVD $25,384,000.00
  • AISP $23,050,213.00
  • Revenue This Year
  • IVVD $606.63
  • AISP $34.30
  • Revenue Next Year
  • IVVD $83.30
  • AISP $59.47
  • P/E Ratio
  • IVVD N/A
  • AISP N/A
  • Revenue Growth
  • IVVD N/A
  • AISP 87.41
  • 52 Week Low
  • IVVD $0.36
  • AISP $1.90
  • 52 Week High
  • IVVD $2.74
  • AISP $8.44
  • Technical
  • Relative Strength Index (RSI)
  • IVVD 38.07
  • AISP 44.32
  • Support Level
  • IVVD $0.46
  • AISP $3.15
  • Resistance Level
  • IVVD $0.56
  • AISP $3.95
  • Average True Range (ATR)
  • IVVD 0.06
  • AISP 0.34
  • MACD
  • IVVD 0.01
  • AISP -0.01
  • Stochastic Oscillator
  • IVVD 29.24
  • AISP 51.04

About IVVD Invivyd Inc.

Invivyd Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of antibody-based solutions for infectious diseases with pandemic potential. The company is developing antibodies to transcend the limits of naturally occurring immunity and provide superior protection from viral diseases, beginning with COVID-19. The company's product candidates are; ADG20 developed for the treatment and prevention of coronavirus disease, and VYD222, a monoclonal antibody candidate engineered, optimizing for potency and breadth of coverage, as well as providing a higher probability of retaining its utility for a longer duration in an evolving viral landscape.

About AISP Airship AI Holdings Inc.

Airship AI Holdings Inc is a robust AI-driven data management platform that solves complex data challenges for large institutions operating in dynamic and mission-critical environments with rapidly increasing volumes of data being ingested from a similarly rapidly growing number of data sources. Its primary offerings include Outpost AI, Acropolis, and Airship Command. Its offerings allow customers to manage their data across the full data lifecycle, when and where they need it, using a highly secure permission-based architecture.

Share on Social Networks: